diminazene has been researched along with Hypertension in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, TL; Mayence, A; Vanden Eynde, JJ | 1 |
| Dos Santos, RL; Mill, JG; Pimentel, EB; Rouver, WN; Sartório, CL | 1 |
| Duan, W; Liu, J; Ma, Y; Xia, L; Yu, S; Zhai, M; Zhang, L; Zhu, H | 1 |
| Batlle, D; Haber, PK; Haque, SK; Maier, C; Wysocki, J; Ye, M | 1 |
| Burrell, LM; Patel, SK; Velkoska, E | 1 |
| Castro, CH; Ferreira-Neto, ML; Freiria-Oliveira, AH; Lopes, PR; Macedo, LM; Marques, SM; Moreira, MC; Pedrino, GR; Pinto, IS; Rebelo, AC; Reis, AA; Rosa, DA; Silva, CC | 1 |
| Burrell, LM; Griggs, K; Patel, SK; Velkoska, E | 1 |
| Kulemina, LV; Ostrov, DA | 1 |
3 review(s) available for diminazene and Hypertension
| Article | Year |
|---|---|
Some non-conventional biomolecular targets for diamidines. A short survey.
Topics: Amidines; Animals; Diabetes Mellitus, Type 2; DNA; Enzymes; Humans; Hypertension; Ion Channels; Myotonic Dystrophy; Neoplasms; Neurodegenerative Diseases; Proteins; RNA; Thrombosis | 2014 |
The role of SARS-CoV-2 target ACE2 in cardiovascular diseases.
Topics: Angiotensin-Converting Enzyme 2; Animals; Arrhythmias, Cardiac; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Diminazene; Heart Failure; Humans; Hypertension; Myocardial Infarction; Recombinant Proteins | 2021 |
Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pressure regulation.
Topics: Angiotensin-Converting Enzyme 2; Blood Pressure; Cardiovascular System; Diminazene; Enzyme Activation; Humans; Hypertension; Peptidyl-Dipeptidase A; Trypanocidal Agents | 2016 |
5 other study(ies) available for diminazene and Hypertension
| Article | Year |
|---|---|
Acute hypotensive effect of diminazene aceturate in spontaneously hypertensive rats: role of NO and Mas receptor.
Topics: Animals; Blood Pressure; Diminazene; Hypertension; Male; Nitric Oxide; Rats | 2020 |
Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diminazene; Disease Models, Animal; Glutamyl Aminopeptidase; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Leucine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Xanthones | 2014 |
Association of exercise training and angiotensin-converting enzyme 2 activator improves baroreflex sensitivity of spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme 2; Animals; Baroreflex; Blood Pressure; Diminazene; Heart Rate; Hypertension; Male; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Rats; Rats, Inbred SHR; Signal Transduction | 2016 |
Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.
Topics: Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diminazene; Female; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley | 2016 |
Prediction of off-target effects on angiotensin-converting enzyme 2.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Chromatography, High Pressure Liquid; Diminazene; Dose-Response Relationship, Drug; Enzyme Activation; High-Throughput Screening Assays; Humans; Hypertension; Kinetics; Models, Molecular; Peptides; Peptidyl-Dipeptidase A; Prescription Drugs; Protein Binding; Small Molecule Libraries; Substrate Specificity; Thermodynamics; United States; United States Food and Drug Administration | 2011 |